Streetbeat News

Earnings

DKL

Delek Logistics Partners reported worse-than-expected Q2 financial results, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 4:54 pm

AAPL

AMD

AMZN

META

MSFT

NVDA

PLTR

SPY

TSLA

The article discusses the concept of customer positioning, using options flow data to gauge market sentiment. It uses AMD as an example to explain aggregated and expiration-based positioning. The S&P 500 dipped 3% last week due to AAPL's earnings miss and slowed growth, causing a 7% drop in AAPL. AMZN registered a 5% increase over the week. The article also highlights six stocks to watch for the next week based on their positioning patterns: NVDA, MSFT, META, TSLA, AAPL, and PLTR.

Portfolio Pulse from Tradytics

August 07, 2023 | 4:49 pm

FDS

MSFT

TSLA

Despite Q2 earnings surpassing Wall Street's expectations, S&P 500 companies have experienced an unexpected decrease in stock prices. FactSet Research Systems Inc. (FDS) data shows that companies beating Q2 2023 earnings estimates saw an average price decrease of 0.5%. Notable examples include Tesla Inc. (TSLA) and Microsoft Corp. (MSFT), whose stock prices fell by 10.5% and 5.3% respectively, despite positive earnings. Analysts suggest overvaluation as a potential cause, with the S&P 500's forward 12-month P/E ratio currently standing at 19.2, higher than the 5-year and 10-year averages.

Portfolio Pulse from Piero Cingari

August 07, 2023 | 4:41 pm

TEAM

Atlassian's shares are trading lower, pulling back after a surge on Friday due to strong Q4 results.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 4:11 pm

AXSM

BIIB

SAGE

Axsome Therapeutics reported Q2 sales of $46.7 million, beating the consensus of $40.19 million. Sales from Auvelity, a prescription oral medicine for major depressive disorder (MDD), reached $27.6 million. The FDA's rejection of Sage Therapeutics and Biogen's zuranolone for MDD is seen as a positive for Axsome's Auvelity. Analysts believe this will increase Auvelity's competitive edge as a novel-acting branded antidepressant.

Portfolio Pulse from Vandana Singh

August 07, 2023 | 4:07 pm

TWKS

Thoughtworks Holding (NASDAQ:TWKS) is set to release its latest quarterly earnings report on Tuesday, 2023-08-08. Analysts estimate an earnings per share (EPS) of $0.04. The company's past performance shows a pattern of share price changes following earnings reports. The stock is currently trading at $7.08, down 57.82% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 4:02 pm

TGLS

Tecnoglass (NASDAQ:TGLS) is set to release its latest quarterly earnings report on Tuesday, 2023-08-08. Analysts estimate an earnings per share (EPS) of $0.98. The company's past performance shows a trend of beating EPS estimates, which has often led to an increase in share price. The stock is currently trading at $46.4, up 85.38% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 4:02 pm

LCII

LCI Indus (NYSE:LCII) is set to release its quarterly earnings report on August 8, 2023. Analysts estimate an EPS of $1.37. The company's past performance shows a mixed impact on the share price post-earnings release. The stock is currently trading at $134.53, up 6.96% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 4:01 pm

ENR

Energizer Hldgs (NYSE:ENR) is set to release its latest quarterly earnings report on Tuesday, 2023-08-08. Analysts estimate an earnings per share (EPS) of $0.66. The company's past performance shows a pattern of beating EPS estimates, which often leads to an increase in share price. The stock is currently trading at $36.1 and has seen a 15.83% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 4:01 pm

NOVT

Novanta (NASDAQ:NOVT) is set to release its latest quarterly earnings report on August 8, 2023. Analysts estimate an earnings per share (EPS) of $0.72. The company's past performance shows a trend of beating EPS estimates, which has generally led to an increase in share price. The stock is currently trading at $173.41, up 17.48% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 4:01 pm